ArticleScience advances2026
Magnetically gated millimeter-scale capsule power system for leadless electrotherapy.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Temporary cardiac pacing is indispensable for bridging transient bradyarrhythmic indications over days to weeks, yet existing systems remain constrained by device dimensions, surgical complexity, patient burden, and intrinsic operational principles. Here, these challenges are addressed through a millimeter-scale capsule power system with magnetically gated activation via a reed switch, which eliminates the stringent orientation and implantation-depth requirements of optically controlled approaches. In contrast to conventional reed switch-based pacemakers, this capsule system extends the functionality of the reed switch by integrating electrode materials directly onto its surface, thereby enabling a monolithic miniaturized architecture. Pulsed magnetic fields wirelessly actuate intermittent switching, enabling controlled discharge, with robust cardiac pacing demonstrated in large animals. A proof-of-concept closed-loop system is further realized, establishing the feasibility of future integration with a wearable electronic module to enable autonomous electrotherapy upon arrhythmia detection. Collectively, this strategy addresses a key limitation in temporary pacing and may provide a versatile framework for the development of temporary electrotherapeutic systems across cardiac, neural, and regenerative applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.